CIK 0000898437
- Accelerated filer
Anika Therapeutics, Inc.
Sign in to watch- Ticker
- ANIK
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043145961
- Phone
- +1 781-457-9000
- Business address
- 32 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ANIKA THERAPEUTICS INC, ANIKA RESEARCH INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-02-24 | SHERWOOD CHARLES H President, CEO, Director | Grant or award · Stock Option (Right to Buy) | +39,375 | 39,375 | ||
| 2017-02-24 | Hague Richard Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +11,500 | 11,500 | ||
| 2017-02-24 | Cheung Sylvia Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +11,500 | 11,500 | ||
| 2017-02-24 | Ahn Edward S. Chief Tech & Strategy Officer | Sale | −640 | $49.47 | $32K | 7,260 |
| 2017-02-24 | Ahn Edward S. Chief Tech & Strategy Officer | Grant or award · Stock Option (Right to Buy) | +11,500 | 11,500 | ||
| 2017-02-22 | LAND RAYMOND J Director | Sale | −2,635 | $49.08 | $129K | 13,524 |
| 2017-02-22 | Cheung Sylvia Chief Financial Officer | Option exercise | +5,000 | $10.99 | $55K | 37,725 |
| 2017-02-22 | Cheung Sylvia Chief Financial Officer | Shares withheld for taxes | −1,117 | $49.20 | $55K | 36,608 |
| 2017-02-22 | Cheung Sylvia Chief Financial Officer | Sale | −2,000 | $49.01 | $98K | 34,608 |
| 2017-02-22 | Cheung Sylvia Chief Financial Officer | Option exercise | +5,000 | $6.99 | $35K | 39,608 |
| 2017-02-22 | Cheung Sylvia Chief Financial Officer | Sale | −1,193 | $49.05 | $59K | 38,415 |
| 2017-02-22 | Cheung Sylvia Chief Financial Officer | Sale | −807 | $49.02 | $40K | 37,608 |
| 2017-02-22 | Cheung Sylvia Chief Financial Officer | Option exercise · Stock Appreciation Rights | −5,000 | 0 | ||
| 2017-02-22 | Cheung Sylvia Chief Financial Officer | Option exercise · Stock Option (Right to buy) | −4,193 | 20,000 | ||
| 2017-02-22 | Cheung Sylvia Chief Financial Officer | Option exercise · Stock Option (Right to buy) | −807 | 0 | ||
| 2017-02-16 | WHEELER STEVE E Director | Other disposition | −1,158 | 32,968 | ||
| 2017-01-27 | WHEELER STEVE E Director | Grant or award | +1,994 | 36,081 | ||
| 2017-01-27 | Thompson Jeffery S Director | Grant or award | +1,994 | 16,942 | ||
| 2017-01-27 | SHERWOOD CHARLES H President, CEO, Director | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2017-01-27 | Larsen Glenn R. Director | Grant or award | +1,994 | 6,477 |
Page 20 of 29 · 580 trades